667
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist

, , , , , , , , , & show all
Pages 250-256 | Received 04 Jun 2017, Accepted 18 Jul 2017, Published online: 08 Aug 2017

Figures & data

Table 1. Clinical and demographic characteristics of all subjects.

Table 2. Associations between SNPs and benign prostatic hyperplasia (BPH)/aggressiveness risk.

Table 3. Associations between SNPs and baseline clinical traits in BPH patients.

Table 4. Associations between SNPs and change of clinical traits after treatment in BPH patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.